CLINICAL TRACK
Session IV-A: Making the Choice of Therapy for Crohn’s Disease: How Evidence Impacts Practice

Nov 10 2017
7:55 am - 10:00 am

CLINICAL TRACK
Session IV-A: Making the Choice of Therapy for Crohn’s Disease: How Evidence Impacts Practice

Parallel with Nursing and Advanced Practice Track IV-B: Multidisciplinary IBD Patient Management
Co-Moderators: Nilesh Chande, MD and Miguel D. Regueiro, MD, FACG

7:55 am

Welcome and introduction
Stephen B. Hanauer, MD, FACG, Richard P. MacDermott, MD, MACG, and Miguel D. Regueiro, MD, FACG

8:00 am

Presentation on Cochrane Reviews
Nilesh Chande, MD

8:10 am

Presentation #1: Use of anti-TNF therapies for Crohn’s disease
Siddharth Singh, MD, MBBS, MS

8:30 am

Presentation #1: Cases with debate and discussion
Panelists: Brian G. Feagan, MD, FACG, Stephen B. Hanauer, MD, FACG, William J. Sandborn, MD, FACG, Bruce E. Sands, MD, MS, FACG, and Siddharth Singh, MD, MBBS, MS

8:40 am

Presentation #2: Vedolizumab as a treatment for Crohn’s Disease: Efficacy and safety
William J. Sandborn, MD, FACG

9:00 am

Presentation #2: Cases with debate and discussion
Panelists: Brian G. Feagan, MD, FACG, Stephen B. Hanauer, MD, FACG, William J. Sandborn, MD, FACG, Bruce E. Sands, MD, MS, FACG, and Siddharth Singh, MD, MBBS, MS

9:10 am

Presentation #3: Ustekinumab as a treatment for Crohn’s disease: Efficacy and safety
Brian G. Feagan, MD, FACG

9:30 am

Presentation #3: Cases with debate and discussion
Panelists: Brian G. Feagan, MD, FACG, Stephen B. Hanauer, MD, FACG, William J. Sandborn, MD, FACG, Bruce E. Sands, MD, MS, FACG, and Siddharth Singh, MD, MBBS, MS

9:40 am

Concluding remarks and Q&A period

10:00 am

Break